Soricimed Biopharma Inc - Product Pipeline Analysis, 2018 Update

Soricimed Biopharma Inc - Product Pipeline Analysis, 2018 Update

  • Products Id :- GDME195220PD
  • |
  • Pages: 27
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary


Soricimed Biopharma Inc (Soricimed Biopharma), formerly BioProspecting NB Inc is a drug and diagnostic developer that offers pain management solutions. The company offers services such as development and commercialization of therapeutic and diagnostic programs. Its oncology management platform arises from the ability of soricidin and the C-series peptides to modulate the activity of a calcium ion channel. Soricimed Biopharma's products are used in the treatment of breast cancer, ovarian cancer, and prostate cancer, and other cancer types. The company operates through a network of contract research organizations that provide research outside its core capacities. Soricimed Biopharma is headquartered in Moncton, New Brunswick, Canada.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.


- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company Soricimed Biopharma Inc

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides detailed description of products in development, technical specification and functions

- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

- To formulate effective Research & Development strategies

- Develop market-entry and market expansion strategies

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

Read More

Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications


Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 3

Soricimed Biopharma Inc Company Overview 4

Soricimed Biopharma Inc Company Snapshot 4

Soricimed Biopharma Inc Pipeline Products and Ongoing Clinical Trials Overview 4

Soricimed Biopharma Inc-Pipeline Analysis Overview 7

Soricimed Biopharma Inc-Key Facts 7

Soricimed Biopharma Inc-Major Products and Services 8

Soricimed Biopharma Inc Pipeline Products by Development Stage 9

Soricimed Biopharma Inc Pipeline Products Overview 11

Diagnostic SOR-D01 Assay-Breast Cancer 11

Diagnostic SOR-D01 Assay-Breast Cancer Product Overview 11

Diagnostic SOR-D01 Assay-Ovarian Cancer 12

Diagnostic SOR-D01 Assay-Ovarian Cancer Product Overview 12

Diagnostic SOR-D01 Assay-Prostate Cancer 13

Diagnostic SOR-D01 Assay-Prostate Cancer Product Overview 13

Diagnostic SOR-D02 Assay-Breast Cancer 14

Diagnostic SOR-D02 Assay-Breast Cancer Product Overview 14

Diagnostic SOR-D02 Assay-Ovarian Cancer 15

Diagnostic SOR-D02 Assay-Ovarian Cancer Product Overview 15

Diagnostic SOR-D02 Assay-Prostate Cancer 16

Diagnostic SOR-D02 Assay-Prostate Cancer Product Overview 16

Soricimed Biopharma Inc-Key Competitors 17

Soricimed Biopharma Inc-Key Employees 18

Soricimed Biopharma Inc-Locations And Subsidiaries 19

Head Office 19

Recent Developments 20

Soricimed Biopharma Inc, Recent Developments 20

Mar 19, 2018: Soricimed Appoints Dr. Marc Rubin And Mr. Vaughn Embro-Pantalony As Board Directors 20

Jan 26, 2016: Soricimed Welcomes Bob Cory, PhD, to Executive Team and Appoints Tom Reeves to Chair 20

May 06, 2015: Soricimed's Findings Support TRPV6 as a Novel and Significant Biomarker for Ovarian Cancer-Targeted Therapies and Diagnostics 21

Mar 18, 2014: Soricimed Biopharma Announces New VP of R&D 21

Nov 09, 2012: Soricimed CEO Builds BioTech in New Brunswick. CEO Paul Gunn presents innovative business model at NBHRF 22

Oct 23, 2012: Soricimed Biopharma Announces Initiation of Cancer Diagnostic Study With Potential To Detect Stage One Cancer 22

Oct 23, 2012: Soricimed Announces Initiation Of Cancer Diagnostic Study With Potential To Detect Stage One Cancer 23

Appendix 24

Methodology 24

About GlobalData 26

Contact Us 26

Disclaimer 27

List of Figures

Soricimed Biopharma Inc Pipeline Products by Equipment Type 5

Soricimed Biopharma Inc Pipeline Products by Development Stage 9

List of Tables

Soricimed Biopharma Inc Pipeline Products and Ongoing Clinical Trials Overview 4

Soricimed Biopharma Inc Pipeline Products by Equipment Type 5

Soricimed Biopharma Inc Pipeline Products by Indication 6

Soricimed Biopharma Inc, Key Facts 7

Soricimed Biopharma Inc, Major Products and Services 8

Soricimed Biopharma Inc Number of Pipeline Products by Development Stage 9

Soricimed Biopharma Inc Pipeline Products Summary by Development Stage 10

Diagnostic SOR-D01 Assay-Breast Cancer-Product Status 11

Diagnostic SOR-D01 Assay-Breast Cancer-Product Description 11

Diagnostic SOR-D01 Assay-Ovarian Cancer-Product Status 12

Diagnostic SOR-D01 Assay-Ovarian Cancer-Product Description 12

Diagnostic SOR-D01 Assay-Prostate Cancer-Product Status 13

Diagnostic SOR-D01 Assay-Prostate Cancer-Product Description 13

Diagnostic SOR-D02 Assay-Breast Cancer-Product Status 14

Diagnostic SOR-D02 Assay-Breast Cancer-Product Description 14

Diagnostic SOR-D02 Assay-Ovarian Cancer-Product Status 15

Diagnostic SOR-D02 Assay-Ovarian Cancer-Product Description 15

Diagnostic SOR-D02 Assay-Prostate Cancer-Product Status 16

Diagnostic SOR-D02 Assay-Prostate Cancer-Product Description 16

Soricimed Biopharma Inc, Key Employees 18

Glossary 25

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@]

WEX Pharmaceuticals Inc

MaRS Innovation

NovaBioMed Inc

Soricimed Biopharma Inc, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies

select a license
Single User License
USD 750 INR 51465
Site License
USD 1500 INR 102930
Corporate User License
USD 2250 INR 154395



The report was very informative and gives me an interesting view on the Indian market....

We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help...

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...

Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India


Company Brochure

Engage with Us

sales [@]